Sydney, Wednesday 15 February 2012
Cellmid Limited (ASX: CDY) advises that it has received TGA registration for its Évolis™ hair growth product range as “listed medicine”. The registration certificates for the Évolis™ for Men and Évolis™ for Women products include the important claims of “promotes hair growth”, “helps prevent hair loss and thinning” and “restores the natural hair growth cycle”.
Click here to read more »